Profile avatar
herbloongmd.bsky.social
Medical Oncologist w/ interests in #lungcancer, #sarcoma & #drugdevelopment | Associate Professor, Department of Clinical Oncology & Deputy Medical Director, Phase 1 Clinical Trials Centre, CUHK
9 posts 50 followers 100 following
Regular Contributor
Posts 14 Comments 0

Norman Ng – a remarkable figure in the fight against cancer in Hong Kong - Jemma Arakelyan @drjemm.bsky.social oncodaily.com/blog/jemma-a... #Cancer #Medicine #Health #FightAgainstCancer #HongKong #Oncology #OncoDaily

submitted 5 days ago • 0 comments

Matt Krebs on NHS England ctDNA pilot To make ctDNA cost effective, tissue NGS testing in some patients needs to be stopped How do we (safely) do this? ❇️ Actionable Tier 1 mutation present ➡️ no tissue NGS confirmation needed ❇️ Non-informative ctDNA: still need tissue NGS ❗️Guidelines coming ❗️

submitted 6 days ago • 0 comments

Had to pleasure to welcome Fan Zhang, PhD & #hongkong #Pfizer team 🇭🇰 today brief visit to @CUHKMedicine Dept. Clinical Oncology. Long standing relationship working w/ Pfizer on multiple fronts in #drugdevelopment 💊. Looking forward to more collaborations. #LCSM #Sarcoma

submitted 6 days ago • 1 comment

Our February issue is live!🙌 Featuring #iGAS infections in Australia, Hong Kong #Genome Project, #Thalassemia Registry in Singapore, new #ML tool to guide cervical cancer screening & more! 🖋️Editorial: When #bushfires become the "new normal" 🎨Cover: Ms Desiree Tse from HKGI 🔗 tinyurl.com/ycydsrdz

submitted 9 days ago • 0 comments

Strengthening lung cancer screening in Hong Kong: policy, innovation, and collaborative approaches for early detection and improved outcomes www.hkmj.org/abstracts/v3...

submitted 11 days ago • 0 comments

Looking forward to an amazing #international #oncology event dedicated to #innovations and #advances in oncology care & research at @ascocancer.bsky.social #ASCOBT26 to be held in the dynamic city of #Singapore! 🇸🇬☀️🏖️. Mark your calendars! 🗓️ June 25-27, 2026. #InternationalAffairsCommittee

submitted 13 days ago • 0 comments

Always nice to meet #LCSM #friends from around the #world 🌎! Thanks @iaslc.bsky.social #TTLC25 for providing platform for collaborations, discussions & just hanging out! @vamsivelcheti.bsky.social @aaronmansfield.bsky.social @elaineshummd.bsky.social and many others! @apoddc @apclc @CUHKMedicine

submitted 16 days ago • 0 comments

#Signature #AirportExpress 📸🤳 Heading to @iaslc.bsky.social #TTLC25 in #HuntingtonBeach 🏖️ California 🇺🇸! Long journey of 🚝🛫🚕 but looking forward to in depth discussions and updates in novel #lungcancer 🫁 treatments. #LCSM #drugdevelopment

submitted 19 days ago • 1 comment

Always looking forward to the @myESMO #ESMO Annual Congress and this year’s #ESMO25 location in #Berlin will be amazing! An excellent prelude to upcoming #ESMOAsia25 in Singapore as well 🤗 #LCSM #Sarcoma #precisiononcology #healthpolicy @CUHKMedicine www.esmo.org/meeting-cale...

submitted 20 days ago • 0 comments

#SocialMedia has become a useful resource and tool in designing #optimal patients' management. Together w/ colleagues from @cuhkpharmacy we published our paper on #perceptions in 3.6million #web-based posts on the use of #cancer #immunotherapy. jmir.org/2025/1/e60948/ @CUHKMedicine #CUHKSarcoma

submitted 21 days ago • 0 comments

Happy to have caught up with @CarlosWongHKU of @hkumed and @LSHTM during his visit back to #hongkong. A wonderful collaborator throughout the years. Looking forward to future projects together! #sarcoma #LCSM #costeffectiveness #NGS #realworldevidence @CUHKMedicine #CUHKSarcoma

submitted 23 days ago • 0 comments

Returning home from #Mumbai 🇮🇳 after an intensive 2 days of thought provoking conference at #Illuminate2.0. Had the chance to talk about the importance of #lungcancerscreening and its #policyefforts, as well as how we can ensure the #sustainability and #affordability of #precisiononcology.

submitted 28 days ago • 0 comments

#CTOS2024 #sarcoma 3.6% second primary malignancy rate in kids treated for resectable EWS, majority hematologic. Pending multivariable analysis to delineate whether more chemo/which regimens have highest risk.

submitted 113 days ago • 0 comments

Congrats to the Clear Cell Sarcoma Foundation on this poster #CTOS2024 Awesome, patient & patient-advocate driven work using digital connections to put together real-world datasets.

submitted 115 days ago • 0 comments